[Mirioron]

Well, it depends on what citizenship you have. The point is that if it's expensive in the US now then perhaps in the future it will be cheaper and available elsewhere.

[claudeganon]

The purchasing and marking up of expired drugs/patents and blocking of transition to generic status seem the obvious counterexamples here...

https://hbr.org/2017/04/how-pharma-companies-game-the-system...